• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时检验(POCT):当前技术与未来展望。

Point-of-care testing (POCT): Current techniques and future perspectives.

作者信息

Luppa Peter B, Müller Carolin, Schlichtiger Alice, Schlebusch Harald

机构信息

Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München, Germany.

Nadistrasse 14, 80809 München, Germany.

出版信息

Trends Analyt Chem. 2011 Jun;30(6):887-898. doi: 10.1016/j.trac.2011.01.019. Epub 2011 Mar 21.

DOI:10.1016/j.trac.2011.01.019
PMID:32287536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7125710/
Abstract

Point-of-care testing (POCT) is a laboratory-medicine discipline that is evolving rapidly in analytical scope and clinical application. In this review, we first describe the state of the art of medical-laboratory tests that can be performed near the patient. At present, POCT ranges from basic blood-glucose measurement to complex viscoelastic coagulation assays. POCT shortens the time to clinical decision-making about additional testing or therapy, as delays are no longer caused by transport and preparation of clinical samples, and biochemical-test results are rapidly available at the point of care. Improved medical outcome and lower costs may ensue. Recent, evolving technological advances enable the development of novel POCT instruments. We review the underlying analytical techniques. If new instruments are not yet in practical use, it is often hard to decide whether the underlying analytical principle has real advantage over former methods. However, future utilization of POCT also depends on health-care trends and new areas of application. But, even today, it can be assumed that, for certain applications, near-patient testing is a useful complement to conventional laboratory analyses.

摘要

即时检验(POCT)是检验医学的一个学科领域,其分析范围和临床应用正在迅速发展。在这篇综述中,我们首先描述了可以在患者床边进行的医学检验的现状。目前,即时检验涵盖了从基本血糖测量到复杂的粘弹性凝血分析等各种项目。即时检验缩短了关于进一步检测或治疗的临床决策时间,因为临床样本的运输和准备不再造成延迟,生化检测结果可在护理点快速获得。这可能会带来更好的医疗结果并降低成本。近期不断发展的技术进步推动了新型即时检验仪器的开发。我们回顾了其潜在的分析技术。如果新仪器尚未实际应用,往往很难确定其潜在分析原理是否真的比以前的方法具有优势。然而,即时检验的未来应用还取决于医疗保健趋势和新的应用领域。但是,即便在当下,对于某些应用而言,患者床边检测可被视为对传统实验室分析的有益补充,这一点是可以确定的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/af5c37cf33b2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/865e8014eead/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/0d10960bf38a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/933380ae469e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/af5c37cf33b2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/865e8014eead/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/0d10960bf38a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/933380ae469e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b25/7125710/af5c37cf33b2/gr4.jpg

相似文献

1
Point-of-care testing (POCT): Current techniques and future perspectives.即时检验(POCT):当前技术与未来展望。
Trends Analyt Chem. 2011 Jun;30(6):887-898. doi: 10.1016/j.trac.2011.01.019. Epub 2011 Mar 21.
2
Point-of-care testing in hospitals and primary care.医院和初级保健中的即时检验。
Dtsch Arztebl Int. 2010 Aug;107(33):561-7. doi: 10.3238/arztebl.2010.0561. Epub 2010 Aug 20.
3
Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?即时检验 (POCT) 和循证检验医学 (EBLM) - 它们在临床决策中是否具有优势?
Crit Rev Clin Lab Sci. 2017 Nov-Dec;54(7-8):471-494. doi: 10.1080/10408363.2017.1399336. Epub 2017 Nov 23.
4
Implementation of point-of-care testing in a pediatric healthcare setting.在儿科医疗环境中实施即时检验。
Crit Rev Clin Lab Sci. 2019 Jun;56(4):239-246. doi: 10.1080/10408363.2019.1590306. Epub 2019 Apr 11.
5
Point-of-Care Testing即时检验
6
Barriers to hospital-based clinical adoption of point-of-care testing (POCT): A systematic narrative review.基于医院的即时检测(POCT)临床应用障碍:系统叙述性综述。
Crit Rev Clin Lab Sci. 2016;53(1):1-12. doi: 10.3109/10408363.2015.1054984.
7
[The current method of handling of test samples and medical reimbursement for POCT in Japan].[日本即时检验(POCT)的检测样本处理及医疗报销现行方法]
Rinsho Byori. 2002 Oct;50(10):958-64.
8
Practical challenges related to point of care testing.与即时检测相关的实际挑战。
Pract Lab Med. 2015 Dec 9;4:22-29. doi: 10.1016/j.plabm.2015.12.002. eCollection 2016 Apr 1.
9
Quality in point-of-care testing.即时检验的质量
Expert Rev Mol Diagn. 2003 Sep;3(5):563-72. doi: 10.1586/14737159.3.5.563.
10
Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods.三种即时检测设备与临床化学实验室标准检测方法及患者采血方法报告结果的一致性。
BMC Med Inform Decis Mak. 2022 Sep 22;22(1):248. doi: 10.1186/s12911-022-01999-z.

引用本文的文献

1
Bioluminescence in Clinical and Point-of-Care Testing.临床及即时检测中的生物发光
Biosensors (Basel). 2025 Jul 2;15(7):422. doi: 10.3390/bios15070422.
2
Transformative impact of point-of-care testing in critical care.即时检验在重症监护中的变革性影响。
World J Crit Care Med. 2025 Jun 9;14(2):100623. doi: 10.5492/wjccm.v14.i2.100623.
3
Towards liquid biopsy on chip for Triple Negative Breast Cancer: preliminary results on monitoring circulating miRNA-21 using portable diagnostics.迈向用于三阴性乳腺癌的芯片液体活检:使用便携式诊断设备监测循环miRNA-21的初步结果

本文引用的文献

1
The Cost of Manual Charting.手工绘制图表的成本。
Point Care. 2013 Jun;12(2):67-68. doi: 10.1097/POC.0b013e318265db42.
2
The NIBIB Point of Care Technologies Research Network Center Themes and Opportunities for Exploratory POC Projects.美国国立生物医学成像和生物工程研究所即时检测技术研究网络中心主题及探索性即时检测项目的机遇
Point Care. 2008 Mar;7(1):1-41. doi: 10.1097/POC.0b013e318162f3dd.
3
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.从 11-13 周的母体因素、生物物理和生化标志物预测早发型、中间型和晚发型子痫前期。
Discov Oncol. 2025 Jun 6;16(1):1022. doi: 10.1007/s12672-025-02846-z.
4
Smartphone-assisted portable immunosensor toward on-site detection of tumor necrosis factor-α inhibitor adalimumab for personalized treatment.用于肿瘤坏死因子-α抑制剂阿达木单抗现场检测以实现个性化治疗的智能手机辅助便携式免疫传感器
Mikrochim Acta. 2025 May 23;192(6):366. doi: 10.1007/s00604-025-07230-w.
5
Centrifugation-assisted lateral flow assay platform: enhancing bioassay sensitivity with active flow control.离心辅助侧流分析平台:通过主动流控制提高生物分析灵敏度。
Microsyst Nanoeng. 2025 May 22;11(1):101. doi: 10.1038/s41378-025-00923-5.
6
Risk management in POCT blood glucose monitoring: FMEA approach aligned with ISO 15189:2022.即时检验血糖监测中的风险管理:与ISO 15189:2022一致的失效模式与效应分析方法
PLoS One. 2025 Mar 10;20(3):e0319817. doi: 10.1371/journal.pone.0319817. eCollection 2025.
7
Thirteen serum biochemical indexes and five whole blood coagulation indices in a point-of-care testing analyzer: ideal protocol for evaluating pulmonary and critical care medicine.即时检验分析仪中的13项血清生化指标和5项全血凝血指标:评估肺病和重症医学的理想方案
J Zhejiang Univ Sci B. 2025 Jan 18;26(2):158-171. doi: 10.1631/jzus.B2300433.
8
Cellulose-Based Electrochemical Sensors.基于纤维素的电化学传感器。
Sensors (Basel). 2025 Jan 22;25(3):645. doi: 10.3390/s25030645.
9
Point-of-care tests in the emergency medical services: a scoping review.紧急医疗服务中的即时检验:一项范围综述
Scand J Trauma Resusc Emerg Med. 2025 Feb 3;33(1):18. doi: 10.1186/s13049-025-01329-y.
10
Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections.即时检测对疫苗可预防病毒感染的诊断、治疗和监测的影响。
Diagnostics (Basel). 2025 Jan 7;15(2):123. doi: 10.3390/diagnostics15020123.
Prenat Diagn. 2011 Jan;31(1):66-74. doi: 10.1002/pd.2660.
4
[Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience].[在临床常规中使用血管生成因子(sFlt-1/PlGF 比值)来确诊子痫前期:初步经验]
Z Geburtshilfe Neonatol. 2010 Dec;214(6):234-8. doi: 10.1055/s-0030-1262827. Epub 2011 Jan 4.
5
The role of rotation thromboelastometry in early prediction of massive transfusion.旋转血栓弹力图在大量输血早期预测中的作用。
J Trauma. 2010 Dec;69(6):1403-8; discussion 1408-9. doi: 10.1097/TA.0b013e3181faaa25.
6
Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease.中性粒细胞明胶酶相关脂质运载蛋白作为急性肾病的标志物。
Curr Opin Hematol. 2011 Jan;18(1):11-8. doi: 10.1097/MOH.0b013e3283411517.
7
Rapid molecular detection of tuberculosis and rifampin resistance.快速分子检测结核分枝杆菌及利福平耐药性。
N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.
8
Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents.仪器间国际标准化比值结果的差异:将变异分解为亚组分的模型。
Clin Chem. 2010 Oct;56(10):1618-26. doi: 10.1373/clinchem.2010.146233. Epub 2010 Aug 4.
9
Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping.评估 Xpert Flu A 试剂盒基于核酸扩增的即时检测技术用于甲型流感病毒检测和大流行 H1 亚型鉴定。
J Clin Virol. 2010 Oct;49(2):85-9. doi: 10.1016/j.jcv.2010.07.005. Epub 2010 Jul 31.
10
Copeptin: a biomarker of cardiovascular and renal function.copeptin:心血管和肾功能的生物标志物。
Congest Heart Fail. 2010 Jul;16 Suppl 1:S37-44. doi: 10.1111/j.1751-7133.2010.00177.x.